Commercialization Education |
|
Biomedical Innovation 101 Series Begins January 18 |
|
Fast Forward Medical Innovation and the Department of Internal Medicine are hosting a webinar series to introduce the basic concepts of life science research commercialization and connect clinicians and research investigators with supportive resources.
The six-part webinar series will:
- Describe the importance of commercializing research discoveries with the potential to impact human health
- Outline and describe unique commercialization pathways based on product classification
- Identify additional educational and product development resources.
The webinars will be held Wednesdays, beginning January 18, from 12:00pm-1:00pm.
|
|
New Global Health Commercialization Competition |
|
FFMI is partnering with the Center for Global Health Equity (CGHE) and the William Davidson Institute (WDI) to host the inaugural Global Health Commercialization Competition. The competition will create and support a community of faculty innovators from across the University of Michigan that are actively working on technical solutions to healthcare problems in emerging markets.
There will be two key components – a professional development course (kickoff session is Friday, January 27 from 12:00pm-3:00pm) and a pitch competition in May (proposals due Saturday, April 1).
|
|
2023 Frankel Cardiovascular Center Innovation Challenge Open for Submissions on January 3 |
|
The 2023 Frankel Cardiovascular Center (FCVC) Innovation Challenge will take place on Thursday, May 18, from 3:00pm-5:00pm.
Now in its seventh year, the FCVC Innovation Challenge is an annual pitch competition where teams can win funds for ideas impacting cardiovascular care. In addition, "Just Do It Awards" are selected for low-cost, low-complexity ideas.
Ideas are welcome from anyone in the FCVC community: faculty, staff, trainees, patients, and family members.
|
|
FFMI/FCVC Aikens Innovation Academy Now Accepting Applications |
|
The FFMI/FCVC Aikens Innovation Academy is currently accepting applications/inquiries for its Winter 2023 course, beginning Tuesday, January 31. The Aikens Innovation Academy, a collaboration between the Frankel Cardiovascular Center (FCVC) and FFMI, provides innovation and entrepreneurship education, mentorship, and funding for FCVC faculty, staff, trainees, and patients with any innovation (clinical value or commercial potential) affecting cardiovascular care.
The 2023 course will be virtual and run until Tuesday, April 18. Enrollees will leave with enhanced knowledge of innovation and entrepreneurship concepts, in addition to a well-developed pitch for resources. They will also receive mentorship and an opportunity for early-stage development funding. Visit the FCVC Innovation Program page to see past Innovation Academy enrollees. Please apply here or contact Ashley Schork at ashlscho@umich.edu. |
|
New! Innovation Fellow Program Offers Unique Opportunity |
|
Fast Forward Medical Innovation (FFMI) and the Frankel Cardiovascular Center (FCVC) have launched their inaugural Innovation Fellow Program, a one-year program designed to prepare Ph.D. candidates in the life sciences for a successful career through hands-on learning experiences and direct mentorship from leaders in the field.
|
|
|
Fall 2022 FFMI fastPACE Wraps Up |
|
FFMI wrapped up its 17th cohort of the fastPACE course on Friday, November 11 with a hybrid finale event. 17 project teams from across U-M and the state of Michigan completed the full course and gave their final presentations.
FFMI fastPACE is a project-based, experiential course designed to help academics launch new innovations. The multi-week course matches innovators with expert teaching team members for guidance on the development of a business case for adoption, implementation, or commercialization.
Stay tuned for details on the spring cohort of FFMI fastPACE.
|
|
Congratulations to James Moon, Ph.D. |
|
MTRAC award winner, James Moon, Ph.D., was recently named a 2022 winner of the Mid-career Biosciences Faculty Achievement Recognition Award, which recognizes exceptional mid-career faculty in the biosciences.
The annual award provides discretionary funds to encourage innovative, high-risk research. Moon was one of six U-M scientists and engineers to receive the award.
|
|
Prepare to Write Successful New ARPA-H Grants |
|
The Advanced Research Projects Agency for Health (ARPA-H), modeled on DARPA, is a federal funding program supporting the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone. ARPA-H’s mission focuses on leveraging research advances for real-world impact.
The U-M biomedical research community is invited to attend an informational event about submitting ARPA-H grant applications.
Friday, January 6
3:00PM–4:30PM
Central Campus Classroom Building, Rm 3460
1225 Geddes Ave, Ann Arbor
Panelists:
Christian Macedonia, M.D., COL. US Army (Ret.)
CEO of iReprogram
Former Program Manager at DARPA; Former Commander of Gray Team
Former Chief Medical Advisor to the Chairman of Joint Chiefs of Staff of the U.S. Armed Forces
Indika Rajapakse, Ph.D.
Associate Professor of Computational Medicine and Bioinformatics, Mathematics
Rachel Wallace, Ph.D.
Research Development Officer, U-M Office of Vice President for Research
|
|
HHMI Investigator Program Open for 2023 Applications |
|
OVPR and Foundation Relations will host an information session for the Howard Hughes Medical Institute (HHMI) Investigator program, which is offered every three years and provides long-term funding to scientists who push the boundaries of fundamental science. The competition is open to researchers in basic and biomedical sciences, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology.
Tuesday, January 17
3:00pm-4:30pm
University Hall
Ruthven Administration Building
|
|
Asahi Kasei Pharma Call for Proposals |
|
Asahi Kasei Pharma is calling for new proposals for its Open Innovation program to promote pharmaceutical R&D through enhanced cooperation with universities, research institutes, and enterprises around the world.
Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, renal disease, neurodegenerative disease, bone disease, and drug discovery platform technology. Submissions will be assessed for their potential for collaborative research.
The application period begins at 5:00am GMT (12:00am EST) on Thursday, January 5, 2023, and ends at 8:00am GMT (3:00am EST) on Tuesday, February 28, 2023.
For more information, please contact Debra Grega, FFMI Business Development Director, or visit the Asahi Kasei website. If there is interest, Debra can arrange a discussion with Asahi Kasei. |
|
Resource for Archiving & Sharing Qualitative Data |
|
Request HITS Data Integration and Automation Services |
|
Do you need a SQL query or REDCap data pull automated? A HIPAA-aligned location to store your research data? Infrastructure to scale your study across multiple sites? Or simply a consultation for advice on your data needs? The HITS Academic Integrations team offers a plethora of data integration and automation services to enable your research. Having recently provisioned our 1000th service, we are well versed in providing custom solutions to support the data needs of the Michigan Medicine research and education community.
|
|
To better navigate the complexities of the U-M biomedical research enterprise, visit the Research Project Lifecycle. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
|
|
Fast Forward Medical Innovation is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.
|
|
|
|
|
|
|
